US DRUG WATCHDOG
       The Premier Consumer Advocate For Victims Of Recalled Drugs
       Or Defective Medical Devices In The United States

                                                                                    866-714-6466
 

 HomeAboutServicesPress ReleaseContact

ACTOS  
 




 



ACTOS tm and Bladder Cancer

The US Drug Watchdog Urges Family Members or Loved Ones of Diabetics Who Now Have Bladder Cancer To Ask if They Were Using the Drug Called Actos
tm

The US Drug Watchdog says, "We need the help of loved ones, or family members of diabetics, who now have bladder cancer, if they were, or have also used the drug called Actos.

There appears to be a correlation between US diabetics, bladder cancer, and the drug called Actos, and we want to identify every possible victim." Both Germany and France have suspended sales of Actos. The Actos suspension is effective July 11, 2011. Actos (pioglitazone), along with another diabetes drug made by Takeda Pharmaceutical, Competact, came under fire in Europe after a study revealed an increased risk for bladder cancer among diabetes patients who were taking the medication.

The US Drug Watchdog says, "We want to hear from any user of the diabetes medication called Actos, if they have developed bladder cancer. If after using Actos you, or a loved one developed bladder cancer please call our group immediately at 866-714-6466.
 
     
 
   
 


Call anytime
866-714-6466

 


Americas
Watchdog
.com
National Advocacy Group for Consumer Protection and Corporate Fair Play

 

 

 

Copyright 2012 US Drug Watchdog
www.designbypepper.com